Want to join the conversation?
$DAL generated $1.8Bil of operating cash flow in 3Q16, and deployed more than $650MM of it back in the business, by taking delivery of 11 mainline aircrafts. In 4Q16, the company expects core capital spending to be about $700MM and anticipates spending an additional $520MM on the Aeromexico tender offer.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.